The government does nâ€™t directly negotiate drug prices in Part D of Medicare , nor does it set the cost of The government benefit .   Instead , health plans and PBMs negotiate prices with drug manufacturers and then compete with one another based on price and quality , for market share .   As a result , Part D is the rare Part D of Medicare that has come in   .According to the Congressional Budget Office , total program costs between    were 45 percent less than original projections .